SNDX Syndax Pharmaceuticals Inc

$19.00 -0.31%

Healthcare · Pharmaceutical Preparations

Syndax Pharmaceuticals Inc (SNDX) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $1.7 billion. Shares last traded at $19.00, 25.7% below their 52-week high. Over the past year the stock is up 97.3%. Net profit margin is -165.6%, below the peer median of -0.1%. Revenue grew 627.8% year over year.

Market Cap

$1.7B

Shares Out

88.6M

EPS (TTM)

$-5.79

P/E Ratio

—

P/S Ratio

9.77

P/B Ratio

40.45

Dividend / Share

—

Dividend Yield

—

52-Week High

$25.58

52-Week Low

$8.58

Volume

137,382

Avg Vol (3m)

99,809

Performance

+6.20%

-1.78%

-20.87%

-8.30%

YTD

-10.80%

+97.30%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

48.99

SMA (50)

$20.47

SMA (200)

$19.49

Price vs SMA50

-7.18%

Price vs SMA200

-2.53%

ATR (14)

$1.02

Financials

Revenue

$172M

Net Income

$-285M

Gross Margin

—

Operating Margin

-158.4%

Net Margin

-165.6%

Return on Equity

-685.7%

Return on Assets

-60.4%

Current Ratio

5.47

Debt / Equity

10.36

Revenue Growth (YoY)

+627.8%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.48	2026-04-30
FY 2025	$-3.29	2026-02-26
Q3 2025	$-2.51	2025-11-03
Q2 2025	$-1.82	2025-08-04
Q1 2026	$-0.98	2026-04-30
FY 2025	$-3.72	2026-02-26

Full earnings history →

Pharmaceutical Preparations peers

SNDX vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

9.77 / 3.54 med

+176% premium

Net margin vs peers

-165.6% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.